Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus
Suzanne Russo(Case Western Reserve University), Christopher J. Anker(University of Vermont), J. Eva Selfridge(University Hospitals of Cleveland), Jordan Berlin(Dana-Farber Cancer Institute), Timothy J. Kennedy(Memorial Sloan Kettering Cancer Center), Percy Lee(City Of Hope National Medical Center), Gerard Abood, Christopher L. Hallemeier(Mayo Clinic in Arizona), Navesh Sharma(Penn State Milton S. Hershey Medical Center), Dmitriy Akselrod(University of Vermont), Leila T. Tchelebi(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Vonetta M. Williams(Memorial Sloan Kettering Cancer Center), Krishan R. Jethwa(Mayo Clinic), Edward Kim(Rutgers, The State University of New Jersey), Pari Shah(Memorial Sloan Kettering Cancer Center)
Cited by 1
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445